脂质原药联合晶体:一种针对真菌生物膜的组合疗法平台
Yong Liu1,2,3, Chang Gao1,2,3, Xiao Zhang1,4
1State Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin, 300071, China.
Advanced materials (Deerfield Beach, Fla.)
|August 8, 2025
概括
新型脂质原药联合晶体 (LPCC) 有效地对抗真菌生物膜和炎症. 这种创新的药物输送系统通过同时输送抗真菌药物和抗炎药物来增强抗真菌治疗,改善治疗结果.
科学领域:
- 制药科学 制药科学
- 药物输送系统 药物输送系统
- 菌类学 菌类学是指菌类学.
背景情况:
- 真菌感染通常由生物膜和炎症复杂化,降低了传统抗真菌治疗的有效性.
- 开发先进的药物输送系统对于克服这些治疗挑战至关重要.
研究的目的:
- 开发和评估一种新的混合药物输送平台,即脂质前药物共晶 (LPCC),用于治疗真菌感染.
- 研究LPCCs在预防和根除真菌生物膜和减轻炎症方面的有效性.
主要方法:
- 通过将α-aminophosphonate与酸修饰的双醇 (Bfz) 结合,合成了一种脂质前药物.
- 与非类固醇抗炎药物 (NSAID) 共同结晶脂质前药物,形成LPCCs.
- 评估LPCCs的药物载荷能力,受控释放,生物膜抑制和抗炎作用在体外和在小鼠直肠角膜炎模型中.
主要成果:
- LPCCs表现出高的药物载荷能力 (高达85%) 并与NSAIDs有效地联合结晶.
- 双输送系统提供了受控的,特定地点释放的抗真菌和抗炎药物,以应对生物膜微环境.
- LPCCs显著阻止了生物膜的形成,根除了成熟的生物膜,通过抑制NF-κB/COX-2通路来减少炎症,并在小鼠候群病模型中改善了结果.
结论:
- 脂质前药物共晶体 (LPCC) 是一种有前途的混合药物输送平台,用于真菌感染.
- LPCCs增强抗真菌功效,减少炎症,并提供一种潜在的策略来克服当前治疗方法的局限性.
相关概念视频
01:27Combined Effects of Drugs: Synergism
4.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
4.7K
01:29Biofilms
272
Biofilms are complex communities of microorganisms encased in a self-produced extracellular polysaccharide matrix attached to surfaces. These microbial consortia can include single or multiple species, providing enhanced survival benefits by forming organized, multilayered structures.The formation of biofilms occurs through four key stages: attachment, colonization, development, and dispersal.During attachment, free-swimming planktonic cells adhere to a surface, often facilitated by...
272
01:30Prodrugs
2.8K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.8K